(Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (Q3)Sep 30, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow (Indirect Method) | ||||||||||
Cash flow from continuing operating activities | -1.43%543M | 17.77%636.3M | -37.54%2.39B | -20.43%698.9M | -45.25%604.2M | -49.58%550.9M | -28.80%540.3M | 91.04%3.83B | 31.34%878.3M | 79.45%1.1B |
Net income from continuing operations | -14.13%239.5M | -67.75%185.4M | -30.66%1.6B | -31.67%506.3M | -72.76%236.4M | -63.44%278.9M | 928.39%574.9M | 192.69%2.3B | 9.29%741M | 1,519.03%867.8M |
Operating gains losses | 32.73%-84.9M | 129.17%83.3M | -103.50%-633.5M | 7.39%-274.5M | 113.72%52.8M | 36.49%-126.2M | -150.23%-285.6M | -160.80%-311.3M | 24.43%-296.4M | -196.08%-384.8M |
Depreciation and amortization | -9.68%314.6M | 0.35%340.2M | 7.01%1.41B | -2.91%353.6M | 16.92%364.9M | 10.92%348.3M | 4.82%339M | 23.51%1.31B | 13.78%364.2M | -5.05%312.1M |
Asset impairment expenditure | 225.00%1M | 94.94%-400K | -208.96%-7.3M | -133.33%-1.4M | --2.8M | -128.57%-800K | -2,533.33%-7.9M | 105.02%6.7M | 110.00%4.2M | --0 |
Remuneration paid in stock | -33.33%200K | -25.00%300K | 0.00%1.2M | 0.00%300K | -50.00%200K | 50.00%300K | 33.33%400K | -53.85%1.2M | 0.00%300K | -33.33%400K |
Deferred tax | -48.32%29.2M | -105.20%-4.7M | -33.07%259.3M | -34.34%111.1M | -99.16%1.3M | -61.17%56.5M | 210.78%90.4M | 121.62%387.4M | -24.40%169.2M | 813.02%154.3M |
Other non cashItems | -15.79%3.2M | -54.84%2.8M | 40.80%17.6M | 2.70%3.8M | 18.75%3.8M | 26.67%3.8M | 138.46%6.2M | 34.41%12.5M | 131.25%3.7M | -8.57%3.2M |
Change In working capital | 506.06%40.2M | 116.60%29.4M | -303.06%-245.3M | 99.72%-300K | -138.51%-58M | -115.74%-9.9M | -1,265.13%-177.1M | 129.54%120.8M | 34.57%-107.9M | 200.13%150.6M |
-Change in other current liabilities | -89.21%1.5M | 51.09%-6.7M | 92.80%-9.3M | 88.49%-1.6M | 81.76%-7.9M | 144.55%13.9M | 66.42%-13.7M | 42.53%-129.2M | 75.35%-13.9M | 55.50%-43.3M |
-Change in other working capital | 262.61%38.7M | 122.09%36.1M | -194.40%-236M | 101.38%1.3M | -125.84%-50.1M | -125.29%-23.8M | -391.79%-163.4M | 235.80%250M | 13.36%-94M | 465.16%193.9M |
Cash from discontinued investing activities | ||||||||||
Operating cash flow | -1.43%543M | 17.77%636.3M | -37.54%2.39B | -20.43%698.9M | -45.25%604.2M | -49.58%550.9M | -28.80%540.3M | 91.04%3.83B | 31.34%878.3M | 79.45%1.1B |
Investing cash flow | ||||||||||
Cash flow from continuing investing activities | -38.54%-643.4M | -25.77%-499.8M | -19.64%-1.69B | -23.84%-434.3M | -12.13%-394.6M | -27.62%-464.4M | -14.62%-397.4M | -74.88%-1.41B | -30.52%-350.7M | -53.80%-351.9M |
Capital expenditure reported | -26.68%-527.5M | -3.01%-499.9M | -28.87%-1.84B | -42.63%-538.3M | -7.83%-397.8M | -19.24%-416.4M | -45.95%-485.3M | -35.33%-1.43B | -1.34%-377.4M | -38.16%-368.9M |
Net PPE purchase and sale | ---5M | -100.14%-100K | 1,175.00%117.3M | 44,300.00%44.2M | --0 | --0 | 1,007.58%73.1M | -88.30%9.2M | -120.00%-100K | --3.5M |
Net investment purchase and sale | 59.38%-1.3M | -133.33%-2.8M | 55.00%-5.4M | 90.91%-300K | 91.86%-700K | -3,100.00%-3.2M | ---1.2M | -380.00%-12M | -32.00%-3.3M | ---8.6M |
Net other investing changes | -144.64%-109.6M | -81.25%3M | 124.20%35.2M | 99.67%60.1M | -82.35%3.9M | -224.64%-44.8M | 176.92%16M | -90.47%15.7M | -71.52%30.1M | -42.15%22.1M |
Cash from discontinued investing activities | ||||||||||
Investing cash flow | -38.54%-643.4M | -25.77%-499.8M | -19.64%-1.69B | -23.84%-434.3M | -12.13%-394.6M | -27.62%-464.4M | -14.62%-397.4M | -74.88%-1.41B | -30.52%-350.7M | -53.80%-351.9M |
Financing cash flow | ||||||||||
Cash flow from continuing financing activities | 213.51%102.5M | 30.21%-136.5M | 67.85%-759.6M | 51.58%-265.7M | 69.86%-208M | 87.44%-90.3M | 51.75%-195.6M | -97.11%-2.36B | -28.44%-548.7M | -91.53%-690.1M |
Net issuance payments of debt | 318.63%213.5M | -153.81%-26.1M | 110.56%85.1M | 110.81%17M | 78.15%-31.4M | 114.17%51M | 133.45%48.5M | -9.04%-805.8M | -1.94%-157.3M | 30.45%-143.7M |
Net common stock issuance | 70.26%-16.3M | 89.99%-15.1M | 63.68%-469.3M | 42.69%-181.9M | 82.51%-81.8M | 82.36%-54.8M | 23.30%-150.8M | -279.42%-1.29B | -38.48%-317.4M | -319.84%-467.7M |
Cash dividends paid | -10.55%-101.6M | -8.89%-101.7M | -33.20%-392M | -34.42%-103.1M | -29.66%-103.6M | -34.75%-91.9M | -34.39%-93.4M | -121.11%-294.3M | -62.85%-76.7M | -83.68%-79.9M |
Proceeds from stock option exercised by employees | 55.56%8.4M | 6,100.00%6.2M | -43.54%16.6M | -14.81%2.3M | 633.33%8.8M | -72.73%5.4M | -98.25%100K | 111.51%29.4M | -20.59%2.7M | 0.00%1.2M |
Net other financing activities | ---1.5M | --200K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
Cash from discontinued financing activities | ||||||||||
Financing cash flow | 213.51%102.5M | 30.21%-136.5M | 67.85%-759.6M | 51.58%-265.7M | 69.86%-208M | 87.44%-90.3M | 51.75%-195.6M | -97.11%-2.36B | -28.44%-548.7M | -91.53%-690.1M |
Net cash flow | ||||||||||
Beginning cash position | -75.00%1.1M | -98.07%1.1M | --57.1M | -97.19%2.2M | -96.39%600K | -34.33%4.4M | --57.1M | --0 | 187.50%78.2M | 1,176.92%16.6M |
Current changes in cash | 155.26%2.1M | ---- | -198.07%-56M | 94.79%-1.1M | -97.40%1.6M | -138.38%-3.8M | -886.57%-52.7M | 14,375.00%57.1M | 22.43%-21.1M | 137.84%61.6M |
End cash Position | 433.33%3.2M | -75.00%1.1M | -98.07%1.1M | -98.07%1.1M | -97.19%2.2M | -96.39%600K | -34.33%4.4M | --57.1M | --57.1M | 187.50%78.2M |
Free cash from | -92.19%10.5M | 150.09%136.3M | -76.88%556M | -67.93%160.6M | -71.87%206.4M | -81.89%134.5M | -87.19%54.5M | 152.68%2.4B | 69.13%500.8M | 111.32%733.7M |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
No Data